US$ 22.32
pfizer glp 1 agonist pulls out of GLP-1 race after safety concerns 2 Companies Poised to Capitalize
Description
GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

Tirzepatide was more efficacious in reducing body weight

Here's what's happening and why it matters: GLP-1 receptors aren't just in your gut

This includes integrating the latest clinical trial data and delving into potential signaling pathways and pharmacological mechanisms

Obesity has further been associated with higher disease activity and reduced time to flare
